Covington Guides Merck In $576M Deal For Life Science Biz
Merck & Co., with help from Covington & Burling, has agreed to buy venture capital-backed Calporta Therapeutics Inc., which is developing potential treatments for neurodegenerative disorders including Alzheimer's and Parkinson's diseases,...To view the full article, register now.
Already a subscriber? Click here to view full article